A Single-Source Laboratory Solution for Toxicology, STI & Blood Testing

Accurate results. Fast turnaround.
Provider-focused support. 

Dominion Diagnostics provides definitive urine drug testing and clinical toxicology services for healthcare providers nationwide.

We help you monitor compliance, reduce risk, and make confident clinical decisions.

We are your single-source solution. 

Why It Matters for Your Practice

Turn laboratory testing into actionable insights that support better patient care.

Improve Compliance Monitoring

Accurately track adherence to prescribed medications and identify inconsistencies

Reduce Diversion Risk

Detect misuse or non-prescribed substances with definitive testing methods

support clinical decision making

Clear, reliable results help guide treatment adjustments with confidence

Streamline Practice Workflows

Simplify ordering, reporting, and result access through a single platform

COMPREHENSIVE LABORATORY TESTING SERVICES

We offer a full range of clinical toxicology and drug monitoring services designed to support healthcare providers across multiple specialties.

Our testing solutions help improve compliance, reduce diversion risk, and support better patient outcomes.

DESIGNED FOR CLINICAL WORKFLOWS

URINE DRUG TESTING

Urine Drug Testing is considered the “gold standard” for drug monitoring, with longer lookback windows and more metabolite visibility for insights into how the medications are being processed in the body. 

We offer state-of-the-art analytical methods for presumptive and definitive urine drug testing of parent drugs and/or metabolites with industry-low detection limits to ensure scientifically sound insight into drug elimination and/or usage over time.

We also offer lightning-fast result turnaround time (TAT) typically 24H for Preliminary and 72H for LCMS results. 

Click here to view our Customizable Test Menu. 

THE METHODOLOGIES FOR URINE DRUG TESTING

Enzyme Immunoassay (EIA)

EIA, used for the initial test in the analysis, is designed to detect the presence of multiple drugs and/or drug metabolites. EIA technology involves a specialized enzyme mixed with analyte-specific antibodies. If analyte (drug) is present in the specimen, an active enzyme will form generating a color change that can be measured on a spectrophotometric analyzer. The amount of enzyme formed is proportional to the amount of analyte present in the specimen. EIA provides only a preliminary analytical test result. A more specific alternative chemical method (e.g., UPLC-MS/MS) must be used to obtain a confirmed analytical result.

Photo of scientists testing samples
Enzyme Linked Immunosorbent
Assay (ELISA)

ELISAs are microplate-based assays designed for the detection of either a specific analyte or group of compounds. Unlike an EIA, the ELISA requires a multi-step approach, where the key step requires immobilization of the target antigen. The assay itself can be performed with a number of modifications of the basic procedure including the use of a single or multiple capture antibodies to detect the antigen in a non-competitive manner. Alternatively, the ELISA can be performed as a competitive assay. The latter method is commonly used in commercially available ELISA kits.

Ultra Performance Liquid Chromatography / Tandem Mass
Spectrometry (UPLC-MS/MS)

UPLC-MS/MS is a highly specific method used in the definitive identification of individual drug analytes. Compounds are analyzed by chromatographic separation (UPLC), followed by tandem mass spectrometry (MS/MS). With the addition of the UPLC component, the target compound(s) can be isolated from other sample components using specialized columns and solvents. This “pre-fractionated” sample is then introduced into the mass spectrometer, where it is ionized and fragmented. The detection and identification of specific analyte(s) is made based on the molecular characteristics (i.e., m/z) of both the precursor and product ions. By combining the physical separation capabilities of UPLC with the mass analysis and detection capabilities of tandem mass spectrometry, UPLC-MS/MS serves as the preferred method for the definitive identification and quantification of specific drugs and drug metabolites in biological samples.contact us for more information.

ORAL FLUID TESTING

PROVIDING OUR CLIENTS A SINGLE-SOURCE SOLUTION

Oral fluid drug testing (OFT) is a convenient alternative to urine drug testing (UDT) for circumstances where warranting an alternate method, such as patients who can not void due to renal failure and other situations. A convenient offering when there is no restroom, our oral fluid device is easy to use anywhere. 


Oral Fluid Testing

VIEW ON OUR TEST MENU +

URINE STI TESTING

PROVIDING OUR CLIENTS A SINGLE-SOURCE
DIAGNOSTIC SOLUTION

Whether you are looking to screen for asymptomatic infections or follow ASAM Guidelines, we offer a variety of STI testing via urine, with simple collection and rapid turnaround times. 

AVAILABLE URINE STI TESTING:


Chlamydia + Gonorrhoeae
(Urine)

VIEW ON OUR TEST MENU +


Trichomonas + Mycoplasma

(Urine)

VIEW ON OUR TEST MENU +

BLOOD TESTING

For our Substance Use Disorder Treatment customers, we offer phlebotomy services for a continuation of care. We aim to be your single source solution, and we know that offering on-site phlebotomy ensures better outcomes for patients as they are more likely to be compliant with bloodwork and necessary screening tests.

We carefully screen our phlebotomists to ensure they are adept at handling hard sticks, as well as having the emotional intelligence necessary to handle the anxieties one might have about blood drawn while in recovery. 

We offer specialized logistics support phlebotomy services
and supplies to allow for specimen integrity. Most of our bloodwork results within 24 hours of receipt of the specimen at the laboratory. 

AVAILABLE BLOOD TESTING:


INFECTIOUS DISEASE + STI TESTING (Blood)

LEARN MORE +


WOMEN’S HEALTH/PREGNANCY (Blood)

LEARN MORE +


ORGAN & DISEASE-SPECIFIC PANELS (Blood)

LEARN MORE +


ROUTINE HEMATOLOGY
(Blood)

LEARN MORE +


ROUTINE MICROBIOLOGY
(Blood)

LEARN MORE +


CHEMISTRY TESTS + PANELS
(Blood)

LEARN MORE +

EXPLORE TELEHEALTH SOLUTIONS

Convenient testing support designed to help healthcare organizations
support remote workflows and patient access.

Call us at 401.667.5688
or click below for more information

Hear what some of our customers have to say about us

"I love working with Dominion Diagnostics - our rep is both proactive and responsive, and everyone I've ever spoken to at the lab was helpful. They are a great company."
-Sonia B., Program Director
“We have never had a better lab than Dominion. In the past, we’d be wasting time chasing down results. With Dominion, they’re always where I need them through our interface and their website as backup when our system is down. Our collector is an awesome addition to our clinic. We’ll be Dominion customers for life!”
- Rob C., Clinical Director
“I am beyond satisfied right Dominion’s service… they are super responsive, and they send us a survey every year and actually make improvements on things we ask for. To me, that is excellent customer service."
- Jennifer P., Dosing Nurse
“I’ve always been happy with Dominion but lately I have noticed that everything is just faster, better and easier. Our rep takes care of any issues if they arise. Their billing team is great too.”
-David N., Nurse Manager
"I think they are doing a fantastic job. I really like the research and educational pieces that they send out and I find it helpful for our clinicians. We just did a clinical training and got great feedback from our team!"
- Mark P., CEO
"Your company does a great job of education to our patients, that really sets you apart from the rest."
- Isabella G., Assistant Director
"Dominion runs a tight ship and they keep me informed of everything I need to know without overwhelming me or creating extra work. From billing to collecting and the reports– they always hit the mark."
- Kathy T., Office Manager
"I'm so grateful to Dominion, they help me do a better job in my role. I especially like the weekly report that is available for our team meetings so we can catch any members in crisis in case we haven’t had a chance to read their report."
- Matt B., Recovery Coach
"The best thing about Dominion is its people. We live in a smaller city and they treat us like family… not only do we appreciate the occasional lunch and training, but their trauma-informed approach and excellent patient care means we work as partners, they’re not just a vendor. I am so grateful for our team."
- Angel V., Clinical Coordinator
Scroll to Top

Need Help?

CURRENT CUSTOMERS:

877.734.9600

WANT TO WORK WITH US?

401.667.5688

Mark Peters, Chief Financial Officer of Dominion Diagnostics

Mark Peters

Chief Financial Officer

Mark Peters joined Dominion Diagnostics in 2021 and serves as the company’s Chief Financial Officer. Mr. Peters is responsible for Dominion’s Financial Planning & Analysis, Accounting, and Revenue Cycle Management functions. He has over 25 years of financial, operations, and strategic management experience in public, private equity, and venture capital backed healthcare companies.

His experience includes executive roles at Seikagaku Corporation (Tokyo Stock Exchange), IST (now part of Integra LifeSciences), Health Language (now part of Wolters Kluwer), and management positions with IBM and PricewaterhouseCoopers.  

Mr. Peters is a licensed CPA and graduated with an MBA in Finance from The University of Notre Dame and a BBA in Accounting from The University of Texas. In his personal time, he enjoys the outdoors, sports, reading, and spending time with his family.

Mark A. McSally, Esq.

Chief Operating Officer / General Counsel

Mark A. McSally, Esq. joined Dominion Diagnostics in 1999 as Outside General Counsel and moved internally in 2006 to assume the role of Corporate Counsel.  He currently serves as Dominion’s Chief Operating Officer and General Counsel.

Mr. McSally is responsible for all aspects of Dominion’s legal and regulatory needs, including government relations and corporate compliance.  As Chief Operating Officer, he is involved in all aspects of the operational management of Dominion Diagnostics, providing oversight to the Payer Relations, Clinical Services, Laboratory, Research and Development and Client Services teams. 

Mr. McSally is a seasoned attorney with deep roots in Rhode Island’s South County. Mr. McSally holds a Bachelor of Arts in History, with honors, from the College of the Holy Cross and a Juris Doctorate, with honors, from Suffolk University Law School.  He has and continues to serve on a number of community boards.

Luke Jessen

Vice President, Sales & Marketing

Luke Jessen joined Dominion Diagnostics in 2010 and currently serves as its Vice President of Sales & Marketing.  Luke has over twenty-three years of experience in healthcare, including fifteen years in diagnostics. 

Prior to joining Dominion Diagnostics, Luke spent eight years working in pharmaceuticals and two and a half years educating health care providers on appropriate opioid prescribing as President & Founder of Opioid Compliance Consulting.  After Opioid Compliance Consulting was acquired by Riverside Partners in 2010, Luke joined Dominion Diagnostics as Western Regional Sales Director. 

Luke has a consistent track record of building highly successful sales teams and driving clinically appropriate results. 

He holds a Bachelor of Arts in Political Science from The Colorado College in Colorado Springs, Colorado.  In his free time, Luke enjoys spending time with his family, surfing, mountain biking, fly fishing, hiking, snow/water skiing, and playing pickleball.  Luke also volunteers in his community at Cherry Hills Community Church, where he serves as a Ruling Elder. 

John Hearn

Vice President, Business Development & Payer Relations

John joined Dominion Diagnostics in 2018. In addition to business development responsibilities at Dominion Diagnostics, he manages the payer relations and inside sales teams. John has over 25 years of business development experience with 14 being in the laboratory space.

Before joining Dominion Diagnostics, John was the Chief Marketing Officer for Pathway Diagnostics. His responsibilities included, business development, managing outside sales, compliance, market and business strategy as well as lab operations. Prior to Pathway Diagnostics, he worked for Cordant Health Solutions, where he sold and managed a 5000 specimen a month book of business that grossed over $48 million in annual revenue as well as managed the Southeast sales team. In 2010, he was hired by Quest Diagnostics to be an account executive. His call points were all specialties including OBGYN and pain management.

Prior to working in the healthcare space, he had a sales role with Fidelity Information Services in their risk management and payment processing division. During his career and with two fortune 500 companies, he has won multiple president club awards.

John has a Bachelor of Business Administration degree from the University of Mississippi. John enjoys being outdoors, playing golf and tennis, watching his three kids play sports and traveling with his family.

Jeff Nally

Senior Vice President, RCM & Corporate Compliance Officer

Jeff joined Dominion Diagnostics in 2014 and currently serves as the SVP of Revenue Cycle Management and is also the company’s Corporate Compliance Officer. Jeff has spent his 25+ year career in finance and the past 20 years focused on healthcare revenue cycle management.

Prior to Dominion Diagnostics Jeff lead the shared services center as the Senior Finance Director for The Mentor Network a national network of local health and human services offering community-based services to adults and children with intellectual and development disabilities. Prior to The Mentor Network Jeff spent 9 years at Perkinelmer leaving as the Director of Insurance and Consumer Billing over seeing revenue cycle management in multiple diagnostic laboratories.

Jeff drives revenue cycle management excellence through streamlined operations and better workflow. Jeff can assess distressed situations, quickly managing necessary change while delivering and improving results and employee success.

In his personal time, he enjoys golf, local sports, and spending time with family and friends.  Jeff is certified in health care compliance (CHC) and has a bachelor’s degree from Curry College.

Denise Driscoll, SPHR, CCP

Vice President, Human Resources

Denise Driscoll is an experienced human resource leader across various industry sectors. Her prior experience includes working for national and global organizations.

Ms. Driscoll’s prior healthcare experience includes the creation of a HR shared services organization for a regional healthcare system.  She’s led programs in support of highly engaged employee populations.  She has significant organizational design, compensation, and benefit management experience as well as in-depth experience with mergers and acquisitions. Her employee relations record includes creating and implementing performance and development systems in support of high-performing companies.

At Dominion Diagnostics, Ms. Driscoll is responsible for organizational health and is the senior executive sponsor of the cross-functional Employee Success Team, which fosters employee engagement through communication, wellness initiatives, and programs that promote connection and a strong sense of community.

Denise has a B.A. in Psychology from Drew University, and an M.B.A. with a concentration in HR from San Francisco State University.  In her free time, she enjoys yoga, hiking, listening to live music, and kayaking. Denise is active with the Rhode Island Community Food Bank, where she is Head of the HR Committee and serves on the Board.

David J. Molusis

Vice President, Information Technology

David J. Molusis joined Dominion Diagnostics in 2015 as Vice President of Information Technology. Mr. Molusis has over 25 years of experience as an accomplished healthcare IT leader and administrator. 

Prior to Dominion Diagnostics, Mr. Molusis held the position of Vice President, Sales & Marketing at Nashville based, Common Cents Systems, a software development firm for reference laboratories. Prior to that as Vice President & CIO at Clinical Laboratory Partners, a member of Hartford Health Care Corporation’s integrated healthcare delivery system. Before his role at Clinical Laboratory Partners, Mr. Molusis held a variety of career evolving positions, including Chief Information Officer, at VNA Health Care, the largest home health care organization in Connecticut.  Earlier in his career, he held various roles in IT, project management, software development and optimization. 

Mr. Molusis is also a contributing author to the industry publications of Laboratory Economics in 2007, The Dark Report in 2011, and most recently, Advance for Administrators of the Laboratory in 2014. 

Mr. Molusis holds a Master’s degree in Information Management from Rensselaer Polytechnic Institute, a Bachelor’s degree in Business Administration from Western Connecticut State University and project management certification from Villanova University. In his personal time, he enjoys the beach, skiing, travel, and spending time with his family and friends between Connecticut, Southern Maine and Florida. 

Charlene Johnson, PhD

Senior Vice President, Laboratory Operations & Quality

Dr. Charlene Johnson first joined Dominion Diagnostics in 2003 as the Director of Molecular Testing.  In 2009, she became the Assistant Laboratory Director for Dominion’s Rhode Island and Vermont laboratories. Dr. Johnson assumed the role of Laboratory Director in 2011, followed by Vice President of Laboratory Operations and Laboratory Director in 2013, and was promoted to serve as the company’s Senior Vice President, Laboratory Operations & Quality in 2021.

Under Dr. Johnson’s exemplary leadership, Dominion’s laboratories have expanded tremendously in both capacity and testing capabilities.  She has driven significant achievements in laboratory operations, research and development, and strategic growth.  The company counts on Dr. Johnson’s expertise and guidance to uphold its reputation for sound science and laboratory integrity. 

Prior to joining Dominion, Dr. Johnson worked as a Senior Research Fellow at the University of Texas Health Science Center in Houston, Texas. 

Dr. Johnson holds a Bachelor of Science from the College of William and Mary and received her PhD from Virginia Commonwealth University/Medical College of Virginia.

Carin Johnson

Senior Vice President, Customer Operations

Carin joined the organization in 2015 and currently holds the position of Senior Vice President of Customer Operations. With a career spanning over 30 years in healthcare management, including 16 years of specialization in laboratory diagnostics, she brings invaluable expertise to the industry.

Before joining Dominion Diagnostics, Carin served as the Field Operations Director at Calloway Labs, where she oversaw and directed nationwide operations. In this role, she played a integral role in driving operational improvements, with a strong focus on enhancing the customer experience. This resulted in increased productivity and streamlined procedures, making a substantial impact during her tenure.

Carin holds a Bachelor of Science in Business Management from the University of Maryland. In her free time, she enjoys spending time with her family, as well as running, hiking, and traveling.

Robert M. Garvey, Jr.

Chief Executive Officer

Bob joined Dominion Diagnostics in 2011 and serves as its Chief Executive Officer. He has over 35 years of experience in healthcare, including over three decades of leadership in laboratory diagnostics and diagnostic imaging. 

Prior to Dominion Diagnostics, Bob ran the Northeast division of Laboratory Corporation of America as the Senior Vice President, which generated over $800M in annual revenue. He drove considerable organizational change to improve quality, service levels and foster growth.

Before his role at LabCorp, he spent 12 years at Quest Diagnostics where he held various Vice President and General Manager roles. Early in his career, he held roles in sales and sales management at GE Healthcare. Bob has a proven track record of growing healthcare businesses and developing high performing teams.

He holds a Bachelor of Science in Finance from the University of Massachusetts – Lowell. In his personal time, he enjoys tennis, golf, hockey, traveling, reading and spending time with his family.